Ran Nussbaum

Insider Reports History

Entity
Individual
Location
C/O Kite Pharma, Inc., 2225 Colorado Avenue, Santa Monica, CA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ran Nussbaum:

Insider Reports Filed by Ran Nussbaum

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KROS Keros Therapeutics, Inc. May 30, 2024 1 $0 4 Jun 3, 2024 Director, 10%+ Owner
KROS Keros Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director, 10%+ Owner
KROS Keros Therapeutics, Inc. Nov 29, 2022 6 -$1 4 Nov 30, 2022 Director, 10%+ Owner
URGN UroGen Pharma Ltd. Oct 21, 2022 3 $285K 4/A Feb 28, 2023 Director
URGN UroGen Pharma Ltd. Jun 16, 2022 2 $11.1K 4 Feb 28, 2023 Director
ELOX Eloxx Pharmaceuticals, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
URGN UroGen Pharma Ltd. Jun 8, 2022 2 $0 4 Jun 10, 2022 Director
URGN UroGen Pharma Ltd. Jun 6, 2022 2 $5.15K 4/A Feb 28, 2023 Director
KROS Keros Therapeutics, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director, 10%+ Owner
KROS Keros Therapeutics, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director, 10%+ Owner
ELOX Eloxx Pharmaceuticals, Inc. May 19, 2021 1 $0 4 May 20, 2021 Director
ELOX Eloxx Pharmaceuticals, Inc. May 13, 2021 4 $8M 4 May 17, 2021 Director
URGN UroGen Pharma Ltd. Mar 25, 2021 2 $5.15K 4/A Jun 9, 2021 Director
URGN UroGen Pharma Ltd. Mar 25, 2021 4 $11.1K 4 Jun 9, 2021 Director
KROS Keros Therapeutics, Inc. Apr 7, 2020 0 $0 3/A Nov 30, 2022 Director, 10%+ Owner